BIO-UV Group Past Earnings Performance

Past criteria checks 0/6

BIO-UV Group has been growing earnings at an average annual rate of 21.9%, while the Machinery industry saw earnings growing at 15.4% annually. Revenues have been growing at an average rate of 15.9% per year.

Key information

21.9%

Earnings growth rate

22.0%

EPS growth rate

Machinery Industry Growth10.7%
Revenue growth rate15.9%
Return on equity-2.2%
Net Margin-1.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How BIO-UV Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:4Y4 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2440-190
31 Mar 2441090
31 Dec 2342090
30 Sep 23431100
30 Jun 23441100
31 Mar 23482100
31 Dec 2251290
30 Sep 2250290
30 Jun 2249290
31 Mar 2242280
31 Dec 2135180
30 Sep 2136170
30 Jun 2136170
31 Mar 2135170
31 Dec 2033170
30 Sep 2029060
30 Jun 2026060
31 Mar 2023050
31 Dec 1921050
30 Sep 1919050
30 Jun 1917040
31 Mar 1915040
31 Dec 1813040
31 Dec 1711030
31 Dec 1611230

Quality Earnings: 4Y4 is currently unprofitable.

Growing Profit Margin: 4Y4 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4Y4 is unprofitable, but has reduced losses over the past 5 years at a rate of 21.9% per year.

Accelerating Growth: Unable to compare 4Y4's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4Y4 is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (-8.6%).


Return on Equity

High ROE: 4Y4 has a negative Return on Equity (-2.2%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:47
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BIO-UV Group S.A. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephanie LefebvreGilbert Dupont
Martin TessierStifel, Equities Research
Martin TessierStifel Europe